Skip to content

Company information lookup

PROGEN PHARMACEUTICALS LIMITED (PGL)

Discovery, development and commercialisation of small molecule therapeutics primarily for the treatment of cancer.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
PGL 0.205 0% 0.175 0.215 0.170 0.205 0.170 42,518

PROGEN PHARMACEUTICALS LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code PGL
Securities
Official Listing Date 22 December, 1995
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address http://www.progen-pharma.com
Registered Office Address Level 18, 101 Collins Street, MELBOURNE, VIC, AUSTRALIA, 3000
Head Office Telephone (07) 3273 9133
Head Office Fax (07) 3375 1168
Share Registry COMPUTERSHARE INVESTOR SERVICES PTY LIMITED
117 VICTORIA STREET, WEST END, QLD, AUSTRALIA, 4101
Share Registry Telephone 1300 787 272
Directors / Senior Management
Mr Jitto Arulampalam (Executive Chairman, Non Exec. Chairman)
Mr Heng Tang (Managing Director, Executive Director)
Dr Hongjen Chang (Non Exec. Director)
Company Secretary Mr Blair Lucas
Principal Activities Discovery, development and commercialisation of small molecule therapeutics primarily for the treatment of cancer.

PROGEN PHARMACEUTICALS LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
19/12/2014 asterix PG545 Phase 1 Trial Successfully Completes Third Cohort 2 PDF
20/11/2014   Change of Director's Interest Notice - Mr Jitto Arulampalam 4 PDF
20/11/2014   Change of Director's Interest Notice - Mr Heng Hsin Tang 4 PDF
20/11/2014   Change of Director's Interest Notice - Dr Hongjen Chang 4 PDF
20/11/2014   Issue of Unlisted Options to Contractors & Appendix 3B 13 PDF
20/11/2014   Issue of Unlisted Options to Directors & Appendix 3B 13 PDF
14/11/2014 asterix Notice of Allowance of Canada Patent for PG545 2 PDF
13/11/2014   2014 Form 20-F Filed with the US SEC 93 PDF
07/11/2014   Results of Meeting 2 PDF
07/11/2014   Chairman's Address to Shareholders 2 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
19 Dec 2014 0.205 0% 0.205 0.170 42,518
18 Dec 2014 0.205 20.59% 0.205 0.205 2,667
17 Dec 2014 0.170 -5.56% 0.180 0.170 12,317
16 Dec 2014 0.180 0% 0.180 0.180 80,000
11 Dec 2014 0.180 5.88% 0.180 0.180 5,000

* Volume of shares shown represents only those shares traded on ASX.

PROGEN PHARMACEUTICALS LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security PGL. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security PGL

Warrants & Structured Products

No warrants & Structured Products are available over the security PGL